-- Description:-
Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma.
Scope of the Report:
This report focuses on the Digital Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Digital Therapeutics Market growth is driven by the incidence of preventable chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and a number of benefits offered by digital therapeutics, such as their abilities to induce behavioral change, improve drug adherence, patient convenience, and user-friendliness.
Furthermore, government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus to the growth of this market. The relatively untapped Asia-Pacific market and unexplored therapeutic applications have opened an array of opportunities for the growth of the market. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3443034-global-digital-therapeutics-market-2018-by-manufacturers-regions
For more information or any query mail at [email protected]
The worldwide market for Digital Therapeutics is expected to grow at a CAGR of roughly 30.3% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Proteus Digital Health, Inc.
Omada Health, Inc.
Welldoc, Inc.
Livongo Health
Noom Inc.
Ginger.Io, Inc.
Propeller Health
2morrow Inc.
Canary Health Inc.
Mango Health Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
B2C
B2B
Market Segment by Applications, can be divided into
Preventive
Treatment/Care
There are 15 Chapters to deeply display the global Digital Therapeutics market.
Chapter 1, to describe Digital Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Digital Therapeutics, with sales, revenue, and price of Digital Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Digital Therapeutics, for each region, from 2013 to 2018;
Continued……
Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3443034-global-digital-therapeutics-market-2018-by-manufacturers-regions
Table Of Contents – Major Key Points
1 Market Overview
1.1 Digital Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 B2C
1.2.2 B2B
1.3 Market Analysis by Applications
1.3.1 Preventive
1.3.2 Treatment/Care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Proteus Digital Health, Inc.
2.1.1 Business Overview
2.1.2 Digital Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Proteus Digital Health, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Omada Health, Inc.
2.2.1 Business Overview
2.2.2 Digital Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Omada Health, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Welldoc, Inc.
2.3.1 Business Overview
2.3.2 Digital Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Welldoc, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Livongo Health
2.4.1 Business Overview
2.4.2 Digital Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Livongo Health Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Noom Inc.
2.5.1 Business Overview
2.5.2 Digital Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Noom Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ginger.Io, Inc.
2.6.1 Business Overview
2.6.2 Digital Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ginger.Io, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Continued……
Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3443034
For more information or any query mail at [email protected]
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com
Release ID: 419313
Google
RSS